US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

AZTR Azitra Inc

0.47

0.0036 (0.77%)

Pre Mercado

Última actualización: 05:23:53

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/16/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Andrew Cain McClary

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Azitra (AMEX:AZTR)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024

Haga Click aquí para más Gráficas Azitra.

Azitra (AMEX:AZTR)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024

Haga Click aquí para más Gráficas Azitra.

Noticias sobre Azitra Inc AZTR

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates
Martes 12 de Noviembre 2024 (1 semana hace) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Martes 12 de Noviembre 2024 (1 semana hace) • Edgar (US Regulatory)

Azitra to Present at BIO-Europe 2024
Martes 29 de Octubre 2024 (3 semanas hace) • Business Wire

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
Viernes 11 de Octubre 2024 (1 mes hace) • Business Wire

Form ARS - Annual Report to Security Holders
Miércoles 9 de Octubre 2024 (1 mes hace) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Miércoles 9 de Octubre 2024 (1 mes hace) • Edgar (US Regulatory)

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
Martes 24 de Septiembre 2024 (2 meses hace) • Business Wire

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
Miércoles 18 de Septiembre 2024 (2 meses hace) • Business Wire

Form 144 - Report of proposed sale of securities
Lunes 16 de Septiembre 2024 (2 meses hace) • Edgar (US Regulatory)

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Viernes 6 de Septiembre 2024 (3 meses hace) • Business Wire

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
Miércoles 28 de Agosto 2024 (3 meses hace) • Business Wire

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
Jueves 22 de Agosto 2024 (3 meses hace) • Business Wire

Más de Azitra Inc Artículos de Noticias

Invesco QQQ Trust Series 1

Financial Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones